{"id":3110,"date":"2024-09-04T12:10:04","date_gmt":"2024-09-04T12:10:04","guid":{"rendered":"https:\/\/avaeh.org\/web_nueva_2021\/?p=3110"},"modified":"2024-09-04T12:10:05","modified_gmt":"2024-09-04T12:10:05","slug":"la-pridopidina-de-prilenia-para-la-enfermedad-de-huntington-ha-sido-aceptada-para-la-revision-de-la-autorizacion-de-comercializacion-europea","status":"publish","type":"post","link":"https:\/\/avaeh.org\/web_nueva_2021\/2024\/09\/04\/la-pridopidina-de-prilenia-para-la-enfermedad-de-huntington-ha-sido-aceptada-para-la-revision-de-la-autorizacion-de-comercializacion-europea\/","title":{"rendered":"La pridopidina de Prilenia para la enfermedad de Huntington ha sido aceptada para la revisi\u00f3n de la autorizaci\u00f3n de comercializaci\u00f3n europea"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/news.prilenia.com\/press-releases\/press-release-details\/2024\/Prilenias-Pridopidine-for-Huntingtons-Disease-Accepted-for-European-Marketing-Authorisation-Review\/default.aspx\" target=\"_blank\" rel=\"noreferrer noopener\">LINK AL COMUNICADO COMPLETO<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00a0\u00ab<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.prilenia.com%2F&amp;esheet=54116486&amp;newsitemid=20240903492530&amp;lan=en-US&amp;anchor=Prilenia+Therapeutics+B.V.&amp;index=1&amp;md5=2de7043fd17fe8af7f62120016337ac2\">Prilenia Therapeutics BV<\/a>\u00a0, una empresa de biotecnolog\u00eda en fase cl\u00ednica centrada en la misi\u00f3n urgente de desarrollar nuevas terapias para retardar la progresi\u00f3n de enfermedades neurodegenerativas y trastornos del desarrollo neurol\u00f3gico, anuncia la aceptaci\u00f3n de su solicitud de autorizaci\u00f3n de comercializaci\u00f3n europea (MAA) para pridopidina (45 mg por v\u00eda oral dos veces al d\u00eda) para el tratamiento de adultos con enfermedad de Huntington (EH) por parte de la Agencia Europea de Medicamentos (EMA).\u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LINK AL COMUNICADO COMPLETO \u00a0\u00abPrilenia Therapeutics BV\u00a0, una empresa de biotecnolog\u00eda en fase cl\u00ednica centrada en la misi\u00f3n urgente de desarrollar nuevas terapias para retardar la progresi\u00f3n de enfermedades neurodegenerativas y trastornos del desarrollo neurol\u00f3gico, anuncia la aceptaci\u00f3n de su solicitud de autorizaci\u00f3n de comercializaci\u00f3n europea (MAA) para pridopidina (45 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7,6,4,9,5,58,182,180,8],"class_list":["post-3110","post","type-post","status-publish","format-standard","hentry","category-sin-categoria","tag-asociacion-valenciana-de-enfermedad-de-huntington","tag-avaeh","tag-enfermedad-de-huntington","tag-enfermedades-raras","tag-huntingtons-disease","tag-neurodegenerativa","tag-pridopidina","tag-prilenia","tag-rare-diseases"],"_links":{"self":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/3110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/comments?post=3110"}],"version-history":[{"count":1,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/3110\/revisions"}],"predecessor-version":[{"id":3111,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/3110\/revisions\/3111"}],"wp:attachment":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media?parent=3110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/categories?post=3110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/tags?post=3110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}